These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8573266)

  • 1. [Levels of anti-Gal antibodies in persons infected and non-infected with Trypanosoma cruzi. Probably induced by bacteria and by the parasite].
    González J; Ramírez C; Seguel X; Gutiérrez B; Manque P; Porcile P; Neira I; Sagua H
    Bol Chil Parasitol; 1995; 50(1-2):3-9. PubMed ID: 8573266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies.
    Almeida IC; Milani SR; Gorin PA; Travassos LR
    J Immunol; 1991 Apr; 146(7):2394-400. PubMed ID: 1706399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenic Gal alpha 1----3Gal carbohydrate epitopes are present on pathogenic American Trypanosoma and Leishmania.
    Avila JL; Rojas M; Galili U
    J Immunol; 1989 Apr; 142(8):2828-34. PubMed ID: 2467941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a natural human antibody with anti-galactosyl(alpha 1-2)galactose specificity that is present at high titers in chronic Trypanosoma cruzi infection.
    Avila JL; Rojas M; Velazquez-Avila G
    Am J Trop Med Hyg; 1992 Oct; 47(4):413-21. PubMed ID: 1279994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.
    Umezawa ES; Shikanai-Yasuda MA; Stolf AM
    J Clin Lab Anal; 1996; 10(6):407-13. PubMed ID: 8951611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG subclass reactivity to Trypanosoma cruzi in chronic chagasic patients.
    Hernández-Becerril N; Nava A; Reyes PA; Monteón VM
    Arch Cardiol Mex; 2001; 71(3):199-205. PubMed ID: 11665655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivity of chagasic antigal antibodies with noninfected cells treated with Trypanosoma cruzi secreted/excreted antigens.
    Yokoyama-Yasunaka JK; Piazza RM; Umezawa ES; Stolf AM
    J Clin Lab Anal; 1998; 12(2):108-14. PubMed ID: 9524295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against Trypanosoma cruzi alkaline antigens are elicited in sera from acute but not chronic human chagasic patients.
    Zúñiga E; Montes C; Barbieri G; Gruppi A
    Clin Immunol; 1999 Oct; 93(1):81-9. PubMed ID: 10497014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct lysis of Trypanosoma cruzi: a novel effector mechanism of protection mediated by human anti-gal antibodies.
    Gazzinelli RT; Pereira ME; Romanha A; Gazzinelli G; Brener Z
    Parasite Immunol; 1991 Jul; 13(4):345-56. PubMed ID: 1717927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human chagasic serum contains antibodies capable of inhibiting Trypanosoma cruzi egress from tissue culture cells.
    Costales J; Rowland EC
    J Parasitol; 2005 Aug; 91(4):950-3. PubMed ID: 17089772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to T. cruzi cytosol acidic antigens (FIV) in Chagas' disease recognize parasite cell surface and human heart epitopes.
    Gea S; Gruppi A; Basso B; Menso E; Vottero-Cima E
    J Clin Lab Immunol; 1990 Apr; 31(4):183-7. PubMed ID: 1726727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-alpha-galactosyl antibodies in chagasic patients. Possible biological significance.
    Milani SR; Travassos LR
    Braz J Med Biol Res; 1988; 21(6):1275-86. PubMed ID: 2471563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi.
    Almeida IC; Ferguson MA; Schenkman S; Travassos LR
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):793-802. PubMed ID: 7818483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate epitopes are responsible for antibody cross-reactivity in Trypanosoma cruzi-infected mice.
    Xu BX; Powell MR
    J Parasitol; 1991 Oct; 77(5):808-10. PubMed ID: 1717672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological and structural characterization of an epitope from the Trypanosoma cruzi KMP-11 protein.
    Díez H; Guzmán F; Alba MP; Cuéllar A; Thomas MC; López MC; Rosas F; Velasco V; González JM; Patarroyo ME; Puerta CJ
    Peptides; 2007 Aug; 28(8):1520-6. PubMed ID: 17683828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of anti-Trypanosoma cruzi antibody isotype specificities by western blot in sera from patients with different forms of Chagas' disease.
    Morgan J; Colley DG; Pinto Dias JC; Gontijo ED; Bahia-Oliveira L; Correa-Oliveira R; Powell MR
    J Parasitol; 1998 Jun; 84(3):641-3. PubMed ID: 9645878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vertical transmission of Trypanosoma cruzi in Wistar rats during the acute phase of infection].
    Moreno EA; Rivera IM; Moreno SC; Alarcón ME; Lugo-Yarbuh A
    Invest Clin; 2003 Sep; 44(3):241-54. PubMed ID: 14552062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
    García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
    Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-conventional flow cytometry approaches to detect anti-Trypanosoma cruzi immunoglobulin G in the clinical laboratory.
    Vitelli-Avelar DM; Sathler-Avelar R; Wendling AP; Rocha RD; Teixeira-Carvalho A; Martins NE; Dias JC; Rassi A; Luquetti AO; Elói-Santos SM; Martins-Filho OA
    J Immunol Methods; 2007 Jan; 318(1-2):102-12. PubMed ID: 17161421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of cases of leishmaniasis in the Province of Salta: evidences of mixed infection with Trypanosoma cruzi and Leishmania spp].
    Chiaramonte MG; Zwirner NW; Caropresi SL; Heredia V; Taranto NJ; Malchiodi EL
    Medicina (B Aires); 1996; 56(3):259-68. PubMed ID: 9035482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.